(Q53365999)

13 May 2018

title

Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer (English)

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

1 April 2024

1 reference

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

1 April 2024

12

Ian F Tannock

1 reference

13 May 2018

Mark Clemons

7

object named as

Mark Clemons

1 reference

13 May 2018

author name string

Nadine Tchen

1

1 reference

13 May 2018

Qi-Long Yi

4

1 reference

13 May 2018

Hanxian Hu

5

1 reference

13 May 2018

Irene Chemerynsky

6

1 reference

13 May 2018

Michael Crump

8

1 reference

13 May 2018

David Warr

10

1 reference

13 May 2018

Helen G. Juffs

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615445

1 April 2024

Fiona P. Downie

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615445

1 April 2024

Paul E. Goss

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615445

1 April 2024

Mary E. Tweedale

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615445

1 April 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

13 May 2018

15 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14615445

full work available at URL

1 April 2024

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.01.119

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Journal of Clinical Oncology

1 April 2024

published in

1 reference

13 May 2018

volume

21

1 reference

13 May 2018

issue

22

1 reference

13 May 2018

page(s)

4175-4183

1 reference

13 May 2018

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

cites work

2

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

1 April 2024

3

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature

1 April 2024

4

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Physical and psychologic distress associated with adjuvant chemotherapy in women with breast cancer

1 April 2024

5

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system

1 April 2024

7

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Risk of menopause during the first year after breast cancer diagnosis

1 April 2024

8

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial

1 April 2024

11

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Management of Menopausal Symptoms in Breast Cancer Patients

1 April 2024

12

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

1 April 2024

15

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

1 April 2024

16

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Cognitive function in breast cancer patients receiving adjuvant chemotherapy.

1 April 2024

17

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

The High Sensitivity Cognitive Screen

1 April 2024

20

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Examining the influence of biological and psychological factors on cognitive performance in chronic fatigue syndrome: a randomized, double-blind, placebo-controlled, crossover study

1 April 2024

21

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Cli

1 April 2024

23

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Screening for dementia and investigating its causes

1 April 2024

24

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

1 April 2024

“Mini-mental state”

25

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Transfer of information from touch to vision in brain-injured and emotionally disturbed children

1 April 2024

26

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Effects of tiapride on electroencephalograms and cognitive functions in the elderly.

1 April 2024

27

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 April 2024

28

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B

1 April 2024

30

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Interpreting the significance of changes in health-related quality-of-life scores.

1 April 2024

31

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life

1 April 2024

33

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

The impact of hemoglobin levels on fatigue and quality of life in cancer patients.

1 April 2024

34

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Symptoms and rehabilitation needs of patients with early stage breast cancer during primary therapy

1 April 2024

35

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Benefits of epoetin alfa in anemic breast cancer patients receiving chemotherapy.

1 April 2024

36

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

1 April 2024

37

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Hormone replacement therapy and cognition: systematic review and meta-analysis

1 April 2024

38

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.

1 April 2024

39

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

Cytokine-associated emotional and cognitive disturbances in humans

1 April 2024

40

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993.

1 April 2024

41

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.01.119

1 April 2024

Identifiers

1 reference

13 May 2018

1 reference

13 May 2018